共 34 条
[32]
A double-blind, randomized, multiple-dose, parallel-group study to characterize the occurrence of diarrhea following two different dosing regimens of neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor
[J].
Cancer Chemotherapy and Pharmacology,
2012, 70
:191-199